Longitudinal Rates of Brain Atrophy Differ Across Progressive Supranuclear Palsy Clinical Variants (P1-5.025)
To determine whether longitudinal regional rates of brain atrophy differ across the different clinical variants of progressive supranuclear palsy (PSP).
Authors
- Clifford R. Jack (ORCID: https://orcid.org/0000-0001-7916-622X)
- Farwa Ali (ORCID: https://orcid.org/0000-0001-6060-3995)
- Keith A. Josephs (ORCID: https://orcid.org/0000-0003-2930-8634)
- Mahesh Kumar (ORCID: https://orcid.org/0000-0002-4198-5892)
- Stephen D. Weigand (ORCID: https://orcid.org/0000-0002-4541-9011)
- Mary M. Machulda (ORCID: https://orcid.org/0000-0003-4834-5967)
- Matthew L. Senjem (ORCID: https://orcid.org/0000-0001-9308-9275)
- Christopher G. Schwarz (ORCID: https://orcid.org/0000-0002-1466-8357)
- Yehkyoung C. Stephens (ORCID: https://orcid.org/0000-0003-0761-3283)
- Nirubol Tosakulwong
- Jennifer L. Whitwell (ORCID: https://orcid.org/0000-0001-6914-1563)
Institutions
- Mayo Clinic in Arizona (US)
- Department of Medical Sciences (BY)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210522
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00